The Discounted Cash Flow (DCF) valuation of Collegium Pharmaceutical Inc (COLL) is 37.32 USD. With the latest stock price at 27.01 USD, the upside of Collegium Pharmaceutical Inc based on DCF is 38.2%.
Based on the latest price of 27.01 USD and our DCF valuation, Collegium Pharmaceutical Inc (COLL) is a buy. buying COLL stocks now will result in a potential gain of 38.2%.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 8.3% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 11.50 - 205.16 | 37.32 |
| Upside | -57.4% - 659.6% | 38.2% |